Literature DB >> 7588849

Evaluation of a Lyme disease enzyme immunoassay using the 41-G fragment of flagellin.

S Cretella1, S Gordon, R A Flavell, E Fikrig.   

Abstract

An immunogenic region of the Borrelia burgdorferi flagellin encompassing amino acids 197-273 and designated 41-G was evaluated as an antigen in an enzyme immunoassay (EIA) for Lyme disease on a routine basis in a reference laboratory. Sera that tested positive for Lyme disease by EIA using 41-G or the whole-cell Borrelia burgdorferi lysate as the antigen were also evaluated by immunoblot for reactivity with Borrelia burgdorferi, and the patient's clinical history was determined retrospectively by a questionnaire distributed to the referring physician. The sensitivity of the 41-G based EIA for the serologic diagnosis of Lyme disease, when compared with that of the Borrelia burgdorferi lysate EIA, was 70% (35 of 50). These data demonstrate that 41-G has utility as an antigen in EIA, although the sensitivity is at present less than that of the assay employing the Borrelia burgdorferi whole-cell lysate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588849     DOI: 10.1007/BF01690736

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  15 in total

Review 1.  Laboratory diagnosis of Lyme disease.

Authors:  L A Magnarelli
Journal:  Rheum Dis Clin North Am       Date:  1989-11       Impact factor: 2.670

2.  Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology.

Authors:  L L Bakken; K L Case; S M Callister; N J Bourdeau; R F Schell
Journal:  JAMA       Date:  1992-08-19       Impact factor: 56.272

3.  False-positive IgM antibodies to Borrelia burgdorferi in indirect ELISA as a result of IgM rheumatoid factor.

Authors:  N E Barka; M S Agopian; J B Peter
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

4.  Serologic diagnosis of Lyme disease using recombinant outer surface proteins A and B and flagellin.

Authors:  E Fikrig; E D Huguenel; R Berland; D W Rahn; J A Hardin; R A Flavell
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

5.  Comparison of seven commercial kits for detection of antibodies to Borrelia burgdorferi.

Authors:  J L Schmitz; C S Powell; J D Folds
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-06       Impact factor: 3.267

6.  Reactivity of human Lyme borreliosis sera with a 39-kilodalton antigen specific to Borrelia burgdorferi.

Authors:  W J Simpson; M E Schrumpf; T G Schwan
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

7.  Analysis of the Borrelia burgdorferi GeHo fla gene and antigenic characterization of its gene product.

Authors:  G S Gassmann; E Jacobs; R Deutzmann; U B Göbel
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.490

8.  Comparison of whole-cell antibodies and an antigenic flagellar epitope of Borrelia burgdorferi in serologic tests for diagnosis of Lyme borreliosis.

Authors:  L A Magnarelli; E Fikrig; R Berland; J F Anderson; R A Flavell
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

9.  Western blotting in the serodiagnosis of Lyme disease.

Authors:  F Dressler; J A Whalen; B N Reinhardt; A C Steere
Journal:  J Infect Dis       Date:  1993-02       Impact factor: 5.226

10.  Western blotting in evaluating Lyme seropositivity and the utility of a gel densitometric approach.

Authors:  A R Pachner; N S Ricalton
Journal:  Neurology       Date:  1992-11       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.